MAPT and arteriosclerosis: We conceptualize that persons with higher levels of neurodegenerative proteinopathies (e.g., tau burden) may have more severe arteriosclerosis pathology in parietal and temporal regions, which may contribute to the hypoperfusion seen on neuroimaging studies in patients with Alzheimer’s dementia.